Colchicine Promising in COVID-19 Treatment? Colchicine Promising in COVID-19 Treatment?

Colchicine, an anti-inflammatory drug used to treat gout and rheumatic disease, may be a promising treatment for COVID-19, a randomized, open-label trial suggests.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Cardiology News Source Type: news

Related Links:

This article summarizes the top 20 research studies of 2020 identified as POEMs (patient-oriented evidence that matters), including the two most highly rated guidelines of the year on gout and chronic obstructive pulmonary disease (COPD). Regarding COVID-19, handwashing and social distancing through stay-at-home orders or quarantine measures are effective at slowing the spread of illness. Use of proper face masks (not gaiters or bandanas) is also effective at preventing trans- mission. This is important because the virus can infect others during the presymptomatic phase. Aspirin can no longer be recommended for the primary...
Source: American Family Physician - Category: Primary Care Authors: Source Type: research
AbstractObjectivesThe selected combination was based on limited evidence clinically and in vitro on the efficacy of the Favipiravir and Hydroxychloroquine in SARS-CoV-2. The two medications were listed in many guidelines as treatment options and ongoing trials assessing their efficacy and safety. Thus, we want to prove the clinical effectiveness of the combination as therapy.Trial designThis is an Open label, multicenter, randomized controlled clinical trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. It is a multicenter trial that will compare Favipiravir...
Source: Trials - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Cardiology | Colchicine | Colcrys | COVID-19 | Gout | Heart | Rheumatology